Table 1: Incidence of Discomfort and Adverse Events of MnDPDP in a European Phase 3 Trial (n = 624) (Adapted from [8])

Discomfort or Adverse Event Patients Affected
Number % of total
Discomfort
Sensation of warmth on infusion 20 3.2
Sensation of cold 3 0.5
Injection site pain 2 0.3
Pressure at injection site 1 0.2
Adverse event
Headache 12 1.9
Vomiting 9 1.4
Nausea 8 1.3
Feeling of warmth/flushing 7 1.1
Others 10 1.6